Professor of Psychiatry, Univ of Colorado School of Medicine.
Director, Psychedelic Public Policy Partnership.
Synaptic physiologist studying depression, antidepressant drug actions, and all things psychedelic in mice & people.
Link: BaleThompsonLTP.org
Scott Thompson, PhD
Loading...
CCTSI researcher Joseph Schacht, PhD, is studying how semaglutide (GLP‑1 meds like #Ozempic) could help treat #alcohol use disorder. Findings from his study at our Clinical Translational Research Center show reduced alcohol cravings, consumption, and heavy drinking days. ▶️ buff.ly/oreXkVG
Colorado Clinical and Translational Sciences Institute (CCTSI)
For all you that have been paying close attention, this will not really be news. But pulled together in this excellent article, it brings the impact of the death of American science by a thousand cuts into sharper focus - and urgency! The time for action is here! open.substack.com/pub/27unihte...
This is most definately not OK! A professional academic organization censoring its own leaders for speaking incontrovertible truths. Shameful! www.washingtonpost.com/health/2026/...
Well, that narrows it down!
Not that we're petty or anything, but we're SO CURIOUS about the usefulness of researching fly sterilization these days đź’…
Congratulations, Joe, on your seminal contribution!
But Mr. President......
Scott Thompson, PhD
Scott Thompson, PhD
Scott Thompson, PhD
This is absurd. The administration's proposal would sacrifice the post-war American research system that sparked unprecedented scientific advancement in favor of an ideological loyalty test that would reduce groundbreaking scientific discovery to a game of bureaucratic compliance.
#academicsky
Scott Thompson, PhD
Alt CDC (they/them)
The Office of Management and Budget published long-expected proposed rules for how federal agencies must carry out Trump’s order to put “senior appointees” in charge of deciding who gets funded. The p...
I guess they got the non-woke president they were looking for.
Authored by anonymous current and former NIH workers with experience in peer review, this is an overview of all the changes to NIH's peer review over the last 18 months.
The scientists, including the editor of a leading journal, were handing out copies of an editorial criticizing the Trump administration’s handling of biomedical research.
CCTSI researcher Joseph Schacht, PhD, is studying how semaglutide (GLP‑1 meds like #Ozempic) could help treat #alcohol use disorder. Findings from his study at our Clinical Translational Research Center show reduced alcohol cravings, consumption, and heavy drinking days. ▶️ buff.ly/oreXkVG
Colorado Clinical and Translational Sciences Institute (CCTSI)
